<unk> (Haegarda) is a plasma-derived concentrate of<unk><unk><unk>  (human) <unk> -INH) that is FDA approved for the prevention of hereditary angioedema (HAE) attacks.   Common adverse reactions include injection site reaction, hypersensitivity, nasopharyngitis and dizziness.
C1 esterase inhibitor subcutaneous 
Nasal spray
Desmopressin acetate nasal spray
Medical ventilator
Oxygen concentrator
Asthma spacer
Dextrose monohydrate injection 
H1 antihistamine